Alongside @American_Heart, we have filed an amicus brief supporting the Dementia Prevention and Research Institute of Texas (DPRIT), an initiative approved by nearly 70% of voters to advance research on Alzheimer's disease and related dementias. Despite the clear message sent by the people of Texas, litigation has delayed DPRIT's implementation, but we will continue fighting to see it succeed. Learn more: bit.ly/4gXq6S7.

Read highlights of the scientific advances reported this week at #AAIC26. bit.ly/4aXsaWL

New from #AAIC26: A blood test may help predict risk of cognitive decline due to Alzheimer’s a decade before symptoms appear. Learn More: bit.ly/3ThnRiY

📰 Research News: Alzheimer’s blood test could bring highly accurate diagnosis into everyday clinical care, according to a study reported at #AAIC26. Learn More: bit.ly/3T3trW8

Just in from #AAIC26: Topline results from LiBBY Trial show THC/CBD combination significantly reduces agitation for people with dementia at end of life. Learn More: bit.ly/4yjnAMD

📰 Breaking news from #AAIC26: Lifestyle program improves brain health among older adults at risk for dementia across Latin America — confirming and expanding Alzheimer’s Association-funded U.S. POINTER Trial results. Learn More: bit.ly/4f7dJ3z

📰 #AAIC26 Research Update: Former elite soccer players show evidence of brain health changes in mid-life. Learn More: bit.ly/4fuUcvf.

“Public policy remains — and will always remain — critical to our progress, especially as we think boldly about the future of Alzheimer’s, dementia and brain health.” Our president and CEO @joannepikedrph underscores the continued importance of advocacy. #alzforum

Tonight we recognize @LtGovTX with a Humanitarian of the Year Award for his work in establishing the Dementia Prevention Research Institute of Texas, the largest state-funded dementia research program in the country. #alzforum

Proud moment highlighting brain health research. 🧠 The article reporting the results of the Association’s landmark U.S. POINTER lifestyle intervention trial is included in @JAMA_current’s Research of the Year Roundup. This underscores the significance of U.S. POINTER in shaping the future of brain health. This achievement would not be possible without the dedication of the research teams, study participants and donors. Together, we are building a future where better brain health is within reach for all communities. #ALZResearch #BrainHealth #JAMAROTY25

U.S. POINTER Update: Three @NIHAging-funded ancillary studies report structured healthy lifestyle program previously shown to improve cognition may also improve sleep apnea, blood pressure regulation and cognitive resilience. Read the full release> bit.ly/3MiCTBy #CTAD25 #AlzResearch

Today marks the start of #NationalFamilyCaregiversMonth — a time to honor the incredible strength, compassion and commitment of those caring for loved ones with Alzheimer’s and other dementia. 💜 Join us in celebrating these everyday heroes. Share a tribute to a caregiver in your life at alz.org/honor. Together, we can recognize their impact and raise awareness to #ENDALZ.

For Cathy Harm, #Ride2EndALZ is more than a cycling event - it’s a personal mission to honor loved ones and advance Alzheimer’s research.🧵

Our president & CEO @joannepikedrph urges her fellow Texans to #VoteYesOnAlz14 🗳️ to fund the Dementia Prevention Research Institute of Texas (DPRIT) — creating the largest state-funded Alzheimer’s research program in the country. Read her @dallasnews op-ed to learn more about Proposition 14: bit.ly/3KWQEW5. #ENDALZ

The FDA has cleared the first blood test for Alzheimer’s for use in primary care settings specifically to rule out the presence of amyloid, a hallmark of the disease. “This is another important step toward expanding access to Alzheimer’s disease diagnostic tools,” said our president and chief executive officer @joannepikedrph. The blood test is intended to help primary care physicians determine which patients do not require Alzheimer’s-related follow-up tests, such as PET scans or cerebrospinal fluid analysis. This can significantly improve the diagnostic process by preventing unnecessary specialized testing for individuals whose cognitive issues stem from non-Alzheimer’s causes. The Association is committed to ensuring blood tests are used appropriately and effectively across all care settings. Read our full statement: bit.ly/4oh3Tiu.

Texas is fighting to #ENDALZ at the ballot box 🗳️, and the Association is leading the charge to drive change. Earlier this year, the state legislature established the Dementia Prevention and Research Institute of Texas (DPRIT). Now it’s up to the voters to decide whether or not to fund it. That’s where Proposition 14 comes in. If voters approve Proposition 14 on the November 4 ballot, Texas will invest $3 billion over 10 years for dementia research, creating the largest state-funded dementia research program in the country — becoming a model for other states. We’re incredibly proud to support Proposition 14 and the hope that it will bring to the 460,000 Texans living with Alzheimer’s and their 1 million unpaid caregivers and to all Americans living with dementia. This is a once-in-a-generation opportunity to impact the course of the disease and accelerate research opportunities. Learn more about #VoteYesOnAlz14: bit.ly/4otjBbu.

As the 2025 #alzforum 📣 comes to a close, we thank our advocates who joined us to strengthen the fight to #ENDALZ and to improve the lives of all those impacted by Alzheimer's and other dementia. Your enduring commitment and hope is the driving force of our movement. 💜 You can join our movement by asking your representatives to invest an additional $113.485 million in research funding at the National Institutes of Health (NIH) and $35 million in implementing the BOLD Infrastructure for Alzheimer’s Act at the CDC ➡️ bit.ly/42VytGH

Our advocates at #alzforum are meeting with their representatives right now to support the bipartisan #ASAPAct. This bill would create a pathway for Medicare coverage of FDA-approved dementia blood test screenings. Stand with them: bit.ly/442ieIq.